
Opinion|Videos|February 13, 2025
Clinical and Economic Consequences of Nonadherence to IV Iron
Panelists discuss how nonadherence to IV iron therapy can lead to persistent anemia, worsening symptoms, increased health care utilization and costs, and diminished quality of life, with patients experiencing continued fatigue, reduced work productivity, and increased risk of complications from their underlying conditions.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are the potential clinical and economic consequences of nonadherence to IV iron therapy?
- How does nonadherence to therapy decrease patient quality of life?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
2
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
3
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
4
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
5













































